Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Research has demonstrated sustained growth hormone release following administration: Enhanced binding affinity to GHRH receptors compared to native GHRH Increased resistance to dipeptidyl peptidase-IV enzymatic degradation Sustained elevation of plasma growth hormone concentrations for several hours post-administration Dose-dependent increases in both growth hormone and IGF-1 levels Studies have shown that CJC-1295 increases plasma growth hormone levels by 2- to 10-fold for up to 6 days, with IGF-1 levels remaining elevated for 9-11 days following a single dose in human subjects
In the pharmacokinetic study comparing Nascobal (cyanocobalamin) Nasal Spray and Nascobal (cyanocobalamin) Nasal Gel, the incidence of adverse events was similar
GHK-Cu chelates copper(II) ions and delivers them to cells, activating copper-dependent enzymes essential for collagen crosslinking, antioxidant defense, and tissue remodeling
its breakdown by GGT
Nat Protoc 5 , 5166 (2010)
